New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
09:58 EDTTW, SGNT, MYGN, LII, CMI, OAS, SYT, XPO, SBUX, NBL, MMP, K, CHRW, CSL, STO, WEX, SNE, NFLX, LULU, EDMC, ANR, LNKD, LLL, HHSOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alpha Natural (ANR) upgraded to Neutral from Sell at Citigroup... C.H. Robinson (CHRW) upgraded to Hold from Sell at Stifel... Cummins (CMI) upgraded to Outperform from Market Perform at Wells Fargo... Education Management (EDMC) upgraded to Market Perform at BMO Capital... Kellogg (K) upgraded to Neutral from Underweight at JPMorgan... Lennox (LII) upgraded to Equal Weight from Underweight at Morgan Stanley... lululemon (LULU) upgraded to Outperform from Sector Perform at RBC Capital... Magellan Midstream (MMP) upgraded to Outperform from Market Perform at Wells Fargo... Myriad Genetics (MYGN) upgraded to Neutral from Underperform at Credit Suisse... Netflix (NFLX) upgraded to Buy from Hold at Stifel... Noble Energy (NBL) upgraded to Buy from Neutral at Mizuho... Sagent Pharmaceuticals (SGNT) upgraded to Buy from Neutral at BofA/Merrill... Sony (SNE) upgraded to Buy from Hold at Jefferies... Starbucks (SBUX) upgraded to Outperform from Market Perform at Wells Fargo... Towers Watson (TW) upgraded to Overweight from Neutral at JPMorgan... WEX Inc. (WEX) upgraded to Neutral from Underweight at JPMorgan... XPO Logistics (XPO) upgraded to Buy from Hold at Stifel... Harte-Hanks (HHS) upgraded to Buy from Hold at Noble Financial... Statoil (STO) upgraded to Focus List from Outperform at Howard Weil... Syngenta (SYT) upgraded to Market Perform from Underperform at Bernstein... L-3 Communications (LLL) upgraded at Cowen... Carlisle (CSL) upgraded to Outperform from Market Perform at BMO Capital... Oasis Petroleum (OAS) upgraded to Buy from Hold at Canaccord... LinkedIn (LNKD) upgraded to Buy from Neutral at SunTrust.
News For ANR;CHRW;CMI;EDMC;K;LII;LULU;MMP;MYGN;NFLX;NBL;SGNT;SNE;SBUX;TW;WEX;XPO;HHS;STO;SYT;LLL;CSL;OAS;LNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
January 20, 2015
16:15 EDTNFLXNetflix trades sharply higher after earnings, first look
The stock is up over 12% at time of writing to $393.76 following results in the extended session. At that price resistance is at $395.52. Support is at $386.68.
16:13 EDTNFLXNetflix sees completing global expansion over next two years
Subscribe for More Information
16:10 EDTNFLXNetflix reports Q4 EPS 72c, consensus 45c
Subscribe for More Information
16:08 EDTNFLXNetflix up 11% after reporting better than expected Q4 earnings
Subscribe for More Information
16:07 EDTNFLXNetflix sees Q1 net streaming additions of 4.05M
Subscribe for More Information
16:06 EDTNFLXNetflix sees Q1 EPS 60c, consensus 77c
Subscribe for More Information
16:06 EDTNFLXNetflix reports 4.33M members added in Q4
Subscribe for More Information
16:00 EDTNFLXOptions Update; January 20, 2015
iPath S&P 500 VIX Short-Term Futures down 36c to 35.12 Option volume leaders: AAPL TSLA TWTR GILD NFLX MGM ABX AMAT JNJ C according to Track Data.
15:21 EDTNFLXNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include IBM (IBM), consensus $5.41; Netflix (NFLX), consensus 45c; CA Technologies (CA), consensus 60c; Cree (CREE), consensus 22c; Woodward (WWD), consensus 46c; Fulton Financial (FULT), consensus 21c; Advanced Micro Devices (AMD), consensus 1c; Interactive Brokers (IBKR), consensus 6c; Pinnacle Financial (PNFP), consensus 53c.
14:17 EDTNFLXNetflix technical commentary ahead of earnings
The stock has been in a sideways consolidation pattern since a sharp downtrend began in October of last year. The approximate range has been a high at $350 and a low at $320. Breaks of either end of this range will be important determinants of the trend following earnings. A breakout above $350 would potentially reverse the current dominant downtrend. With over 8.5% of the trading float short, there could be substantial buy-to-cover pressure in the event of a positive surprise. Upside levels to watch above $350 would be at $357.95, $366.51, and $375.83. On an extreme positive surprise, the $380 area could be tested. If the news is negative, a break below the $320 area would likely lead to a resumption of the dominant downtrend. Support levels to watch would be at $310.25, $299.50, and $290.28. A breakdown below $300 would be long-term bearish for price, confirming a major top.
14:04 EDTNFLXNetflix January weekly 345 straddle priced for 11% movement into Q4
Subscribe for More Information
09:36 EDTANRAlpha Natural downgraded to Underweight from Equal Weight at Morgan Stanley
Subscribe for More Information
08:42 EDTOASOasis Petroleum downgraded to Reduce from Neutral at SunTrust
Subscribe for More Information
08:11 EDTNFLXNetflix volatility increases into Q4 and outlook
Subscribe for More Information
07:43 EDTNBLNoble Energy reports no commercial hydrocarbons in Madison exploration well
Noble Energy announced that the Madison exploration well in the Gulf of Mexico reached the targeted Upper and Middle Miocene objectives and did not encounter commercial hydrocarbons. Drilled to a total depth of 16,859 feet on Mississippi Canyon 479, the well has been plugged and abandoned and the drilling rig has been released. Noble Energy operated the well with a 60% working interest and Stone Energy Offshore, had the remaining 40%.
07:25 EDTHHSNoble Financial to hold a conference
Subscribe for More Information
07:07 EDTMYGNMyriad RBM joins Institut Pasteur in TB collaboration
Myriad RBM, a wholly owned subsidiary of Myriad Genetics, announced that it will assist the Institut Pasteur in a public-private research collaboration to fight the global tuberculosis, or TB, epidemic. This research project is funded by the Bill & Melinda Gates Foundation through a grant to the Institut Pasteur. The proof-of-concept study will evaluate patients with latent and active TB infections who are affiliated with the South African Tuberculosis Vaccine Initiative clinical study sites. The goals of this study are to field-test Myriad RBM's TruCulture system as a point-of-care blood collection and immune response monitoring method and to stratify patients with active and latent tuberculosis.
06:10 EDTLULUlululemon implied volatility of 34 at lower end of index mean range
Subscribe for More Information
05:59 EDTSYTSyngenta downgraded to Underweight from Equal Weight at Barclays
January 19, 2015
17:14 EDTCSLCarlisle sees 2014 EBIT margin flat due to 'unexpected circumstances'
Carlisle Companies announced that, while preliminary unaudited results indicate that the company will be reporting record net sales and net earnings for 2014, certain unexpected circumstances at Carlisle Construction Materials and Carlisle Brake & Friction will negatively impact Q4 results. Carlisle said CCM experienced lower sales volume growth in November and December due in part to the early onset of winter conditions in much of the United States, compounded by lower than anticipated demand and the negative impact of foreign currency fluctuations from the stronger U.S. dollar on its sales into Europe. As a result, net sales growth for the CCM segment will be in the mid-single digit percent range in Q4 compared to 16% net sales growth in the prior quarter. For the full year 2014, net sales growth at CCM is estimated to be in the high-single digit percent range. In addition to lower than expected Q4 net sales growth, CCM’s EBIT was negatively impacted by higher costs for plant startups, product line closings, and higher operating costs, the company said. Also in Q4, net sales at CBF will decline modestly versus the prior year quarter due to the "recent well publicized decline in demand in the agriculture markets, the continued malaise in the mining markets, and the negative impact of foreign currency fluctuations from the stronger U.S. dollar." CBF incurred restructuring and severance costs during Q4 in its continued efforts to better align its cost structure with current levels of customer demand. As a result of lower than anticipated performance by CCM and CBF, Carlisle’s overall EBIT margin for 2014 is expected to be level with the prior year. Carlisle’s total net sales growth for 2014 is estimated to be in the high single digit percent range, including sales from the acquisition of LHi Technologies.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use